Date of Award


Document Type


Degree Name

Master of Science (MS)



Committee Member

Agneta Simionescu

Committee Member

Agneta Simionescu

Committee Member

Dan Simionescu

Committee Member

Leslie Sierad


Cardiovascular disease (CVD) is on the rise in the US and is the leading cause of death worldwide [1]. Associated disorders including stenosis of the vasculature and formation of atherosclerotic plaques can necessitate the need for repair or replacement. Tissue engineering, based on stem cells and scaffolds, is an emerging strategy for the treatment of vascular diseases. Patients who typically require vascular replacement often have comorbidities such as diabetes and hypertension. There remains the challenge of understanding the fate of tissue engineered vascular grafts (TEVGs) in a harsh diabetic environment.

In these experiments we aimed to develop an in-vitro vascular bioreactor model to 1) condition our tissue engineered vascular grafts and 2) model both a hyperglycemic and hypertensive environment. Our goal was to illicit an appropriate response from the vascular grafts caused by exposure to these pathologic environments to better inform us regarding the fate of our grafts before requiring an in-vivo model.



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.